270520 — APT Neuroscience Income Statement

0.000.00%

Last trade - 00:00

EnergyHighly SpeculativeSmall CapSucker Stock

Annual income statement for APT Neuroscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	30,370	25,135	17,563	20,415	18,378
Cost of Revenue
Gross Profit	3,452	2,574	-1,463	551	716
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	29,246	26,260	20,701	30,210	37,587
Operating Profit	1,124	-1,126	-3,138	-9,794	-19,209
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-3,620	-1,114	-3,985	-4,457	-19,018
Provision for Income Taxes
Net Income After Taxes	-3,606	-930	-3,248	-5,003	-19,167
Net Income Before Extraordinary Items
Net Income	-3,606	-930	-3,248	-5,003	-19,167
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-3,606	-930	-3,248	-5,003	-19,167
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-43.1	-10.1	-34.5	-23.7	-102
Dividends per Share